Evaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer

NCT05945875 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Panitumumab-IRDye800
OTHER: Indium In 111 Panitumumab
PROCEDURE: Single Photon Emission Computed Tomography
PROCEDURE: Computed Tomography
PROCEDURE: Resection
PROCEDURE: Fluorescence Imaging

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]